Clients in the Media

November 10, 2025 | MeiraGTx
In string of deals, Lilly nabs ultra rare eye disease gene therapy and RNAi partner
Endpoints
October 9, 2025 | LB Pharmaceuticals
Running out of time’: How LB Pharma landed the first big US biotech IPO since February
Endpoints
October 6, 2025 | Abivax
Abivax releases more data from major Phase 3 wins in ulcerative colitis
Endpoints
September 24, 2025 | Sparrow Pharmaceutials
RA and Forbion back Sparrow’s $95M Series B for type 2 diabetes drug
Endpoints
August 21, 2025 | Interius
Gilead joins the in vivo cell therapy race with $350M buyout of Interius
Endpoints
June 26, 2025 | ProFound Therapeutics
Novartis strikes cardiovascular discovery deal with Flagship’s ProFound 
Endpoints
March 13, 2025 | MeiraGTx
MeiraGTx teams with cryptic AI startup, co-founded by Eric Schmidt, to advance Parkinson’s gene therapy
Endpoints
January 14, 2025 | Grifols
Regeneron, Illumina invest in Truveta; Inhibrx Bios $150M loan
Endpoints